ARTLVSCTSO• 6 Months (Normalized)
ARTL vs CTSO (Artelo Biosciences Inc. vs Cytosorbents Corporation)
Showing Closing Date Range from Apr 3 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ARTL Performance $4.54
-92.37%
Artelo Biosciences Inc.
Normalized Baseline0.00%
CTSO Performance $4.91
+%
Cytosorbents Corporation
Normalized Baseline0.00%
Alpha Spread Margin CTSO LEADS
-92.37 pts
CTSO outperforming by 92.37 percentage points
ARTLCTSO
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ARTL CTSO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(121 dates)
| Date | ARTL Price | ARTL Gain (%) | CTSO Price | CTSO Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 25, 2026 | $4.54 | -92.37% | $- | - | |
| Sep 24, 2026 | $5.17 | -91.31% | $- | - | |
| Sep 23, 2026 | $7.31 | -87.71% | $4.91 | +732.20% | -819.91% |
| Sep 22, 2026 | $4.15 | -93.02% | $- | - | |
| Sep 21, 2026 | $4.10 | -93.11% | $5.51 | +833.90% | -927.01% |
| Sep 18, 2026 | $3.94 | -93.38% | $5.75 | +874.58% | -967.96% |
| Sep 17, 2026 | $3.97 | -93.33% | $5.76 | +876.27% | -969.60% |
| Sep 16, 2026 | $3.75 | -93.70% | $5.73 | +871.19% | -964.89% |
| Sep 15, 2026 | $5.34 | -91.02% | $6.06 | +927.12% | -1018.14% |
| Sep 14, 2026 | $4.87 | -91.81% | $6.07 | +928.81% | -1020.62% |
| Sep 11, 2026 | $5.43 | -90.87% | $6.41 | +986.44% | -1077.31% |
| Sep 10, 2026 | $5.63 | -90.54% | $6.37 | +979.66% | -1070.20% |
| Sep 09, 2026 | $5.98 | -89.95% | $6.33 | +972.88% | -1062.83% |
| Sep 08, 2026 | $6.19 | -89.59% | $- | - | |
| Sep 04, 2026 | $6.04 | -89.85% | $0.35 | -40.68% | -49.17% |
Page 1 of 9